Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kees Neef

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|September 23, 2010
[Requirements regarding compounded pharmaceutical preparation]C Kees Neef
European Journal of Hospital Pharmacy : Science and Practice|August 21, 2019
Antimicrobial resistance (AMR)Steffen Amann, Kees Neef, Stephanie Kohl
BMC Health Services Research|July 15, 2020
Drug switching in the Netherlands: a cohort study of 20 active substancesPieter J Glerum, Marc Maliepaard, Vincent de Valk, et al.
Therapeutic Drug Monitoring|August 7, 2016
Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement FluidPaddy K C Janssen, Norbert A Foudraine, Desirée M T Burgers, et al.
Bone|June 27, 2013
Five-year fracture risk estimation in patients with Parkinson's diseaseSander Pouwels, Marloes T Bazelier, Anthonius de Boer, et al.
Critical Care (London, England)|March 3, 2023
Target attainment and population pharmacokinetics of flucloxacillin in critically ill patients: a multicenter studySjoerd D Meenks, Nieko Punt, Jos L M L le Noble, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 21, 2022
Population pharmacokinetics of unbound ceftriaxone in a critically ill populationSjoerd D Meenks, Jos L M L le Noble, Norbert A Foudraine, et al.
Therapeutic Drug Monitoring|June 3, 2014
Development of a pharmacokinetic model of mitotane: toward personalized dosing in adrenocortical carcinomaThomas M A Kerkhofs, Luc J J Derijks, Hester Ettaieb, et al.
Clinical and Translational Science|February 14, 2020
Quantification of Adverse Drug Reactions Related to Drug Switches in The NetherlandsPieter J Glerum, Marc Maliepaard, Vincent de Valk, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|September 23, 2010
[Requirements regarding compounded pharmaceutical preparation]C Kees Neef
European Journal of Hospital Pharmacy : Science and Practice|August 21, 2019
Antimicrobial resistance (AMR)Steffen Amann, Kees Neef, Stephanie Kohl
BMC Health Services Research|July 15, 2020
Drug switching in the Netherlands: a cohort study of 20 active substancesPieter J Glerum, Marc Maliepaard, Vincent de Valk, et al.
Therapeutic Drug Monitoring|August 7, 2016
Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement FluidPaddy K C Janssen, Norbert A Foudraine, Desirée M T Burgers, et al.
Bone|June 27, 2013
Five-year fracture risk estimation in patients with Parkinson's diseaseSander Pouwels, Marloes T Bazelier, Anthonius de Boer, et al.
Critical Care (London, England)|March 3, 2023
Target attainment and population pharmacokinetics of flucloxacillin in critically ill patients: a multicenter studySjoerd D Meenks, Nieko Punt, Jos L M L le Noble, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 21, 2022
Population pharmacokinetics of unbound ceftriaxone in a critically ill populationSjoerd D Meenks, Jos L M L le Noble, Norbert A Foudraine, et al.
Therapeutic Drug Monitoring|June 3, 2014
Development of a pharmacokinetic model of mitotane: toward personalized dosing in adrenocortical carcinomaThomas M A Kerkhofs, Luc J J Derijks, Hester Ettaieb, et al.
Clinical and Translational Science|February 14, 2020
Quantification of Adverse Drug Reactions Related to Drug Switches in The NetherlandsPieter J Glerum, Marc Maliepaard, Vincent de Valk, et al.
Pageof 1